|
KMID : 0614620080510060368
|
|
Korean Journal of Gastroenterology
2008 Volume.51 No. 6 p.368 ~ p.371
|
|
|
Goals of Treatment, Indication, and Treatment for Chronic Hepatits C
|
|
Paik Seung-Woon
|
|
|
Abstract
|
|
|
|
Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatic fibrosis worldwide. Up to 85% of individuals infected with HCV develop chronic infection, which can progress to cirrhosis and hepatocellular carcinoma. The primary goal in the treatment of HCV infection is to reduce the mortality by preventing liver-related deaths associated with the development of hepatocellular carcinoma and decompensated cirrhosis. Pegylated interferons together with ribavirin are currently the standard of care for patients with chronic hepatitis. Here, I discuss the goals of treatment, indication and treatment of chronic hepatitis C. (Korean J Gastroenterol 2008;51: 368-371
|
|
|
KEYWORD
|
|
|
Hepatitis C, Pegylated interferon, Ribavirin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|